American Biomed starts atherectomy Phase II trials:
This article was originally published in Clinica
Executive Summary
Phase II trials of American Biomed's OmniCath atherectomy device have begun at the UCLA Medical Center in California. The study will compare atherectomy with balloon angioplasty in 50-100 patients with occlusive peripheral vessel disease.